Ainos, Inc.

Ainos, Inc. (ticker: AIMD) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of AIMD's SEC filings surfaces 27 active risk signals, including 26 late-filing signals, and 1 auditor-change signal. AIMD reported $161 in revenue and -$2.46M for the period ending 2026-03-31, with operating cash flow of -$983K. Cash and equivalents stood at $2.84M (up 8.1% year-over-year). Total assets of $22.08M exceed total liabilities of $16.39M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.